Back to Search Start Over

Oral mesalamine prevented relapse in patients with Crohn disease who were in remission for < 3 months

Authors :
Arvey I. Rogers
Source :
ACP Journal Club. 119:11
Publication Year :
1993
Publisher :
American College of Physicians, 1993.

Abstract

Source Citation Gendre JP, Mary JY, Florent C, et al. Oral mesalamine (Pentasa) as maintenance treatment in Crohn&#39;s disease: a multicenter placebo-controlled study. Gastroenterology. 1993 Feb;104:4...

Details

ISSN :
15398560 and 10568751
Volume :
119
Database :
OpenAIRE
Journal :
ACP Journal Club
Accession number :
edsair.doi...........11b68f7d0c25338a36d2694e070c3d12